News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert
Mainz Biomed partners with Liquid Biosciences to leverage AI for biomarker selection in PancAlert, a next-gen pancreatic cancer detection test. Companies expand collaboration with promising results and plan to complete analysis by Q4 2024 -
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
Mainz Biomed launches enhanced ColoAlert test with new features to improve screening efficiency and user experience. The updates aim to optimize colorectal cancer detection -